DiaGenic ASA: Termination of Market Making Agreement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: In accordance with the requirements from the Oslo Børs and with reference to the announcement earlier today on implementation of a cost reduction programme, DiaGenic (OSE:DIAG) today announces that it has agreed with Sparebank 1 markets to terminate its market making agreement for DiaGenic shares traded on the Oslo Stock Exchange. Termination will take effect from 28 October 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC